Resistance to obinutuzumab-induced antibody-dependent cellular cytotoxicity caused by abnormal Fas signaling is overcome by combination therapiesNatsumi Kawasaki, Yasushi Yoshimura|Molecular Biology Reports|2022Cited by 11